XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 154 filers reported holding XENON PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.16 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,040,952 | +1357.4% | 1,084,337 | +1542.5% | 0.02% | +1500.0% |
| Q2 2023 | $2,541,616 | -34.2% | 66,016 | -38.9% | 0.00% | -50.0% |
| Q1 2023 | $3,863,960 | +72.4% | 107,962 | +90.0% | 0.00% | +100.0% |
| Q4 2022 | $2,241,004 | -56.5% | 56,835 | -60.2% | 0.00% | -50.0% |
| Q3 2022 | $5,152,000 | -60.6% | 142,726 | -66.8% | 0.00% | -66.7% |
| Q2 2022 | $13,079,000 | +13.6% | 429,960 | +14.2% | 0.01% | +50.0% |
| Q1 2022 | $11,514,000 | +25.3% | 376,651 | +28.1% | 0.00% | +33.3% |
| Q4 2021 | $9,188,000 | +128.6% | 294,098 | +11.8% | 0.00% | +50.0% |
| Q3 2021 | $4,020,000 | +983.6% | 263,103 | +1221.6% | 0.00% | – |
| Q2 2021 | $371,000 | – | 19,908 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 1,594,932 | $48,518,000 | 10.26% |
| GREAT POINT PARTNERS LLC | 1,104,334 | $33,594,000 | 8.06% |
| ACUTA CAPITAL PARTNERS, LLC | 272,500 | $8,289,000 | 4.62% |
| DAFNA Capital Management LLC | 438,623 | $13,343,000 | 3.64% |
| Parkman Healthcare Partners LLC | 294,559 | $8,960,000 | 3.30% |
| Avoro Capital Advisors LLC | 4,900,000 | $149,058,000 | 2.94% |
| Nan Fung Group Holdings Ltd | 114,380 | $3,479,000 | 2.39% |
| BVF INC/IL | 1,597,966 | $48,610,000 | 2.35% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 232,630 | $7,077,000 | 2.18% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 4,391,038 | $133,575,000 | 2.16% |